Omeprazole and Hallucinations - a phase IV clinical study of FDA data

Summary:

Hallucinations is found among people who take Omeprazole, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Omeprazole and have Hallucinations. It is created by eHealthMe based on reports of 351,142 people who have side effects when taking Omeprazole from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Aug, 10, 2023

351,142 people reported to have side effects when taking Omeprazole.
Among them, 2,193 people (0.62%) have Hallucinations.

What is Omeprazole?

Omeprazole has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 360,348 Omeprazole users for its effectiveness, alternative drugs and more.

What is Hallucinations?

Hallucinations (sensations that appear real but are created by your mind) is found to be associated with 3,199 drugs and 2,618 conditions by eHealthMe.

Number of Omeprazole and Hallucinations reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Omeprazole and have Hallucinations?

Check whether Hallucinations is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Ezeji GC, Inoue T, Bahtiyar G, Sacerdote A, "Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism", BMJ case reports, 2015 Feb .
Boschee T, DO PGY II, "Acute Hallucinations: Where Did That Come From?", , 2007 Jan .

Related studies

How severe was Hallucinations and when was it recovered:

Hallucinations in Omeprazole

Expand to all the drugs that have ingredients of omeprazole:

Hallucinations and drugs with ingredients of omeprazole (2,921 reports)

Alternative drugs to, pros and cons of Omeprazole:

Omeprazole (360,348 reports)

Common Omeprazole side effects:

Fatigue (feeling of tiredness): 22,124 reports
Diarrhea: 20,827 reports
Chronic kidney disease: 19,690 reports
Breathing difficulty: 18,194 reports
Drug ineffective: 17,125 reports
Pain: 15,867 reports
Dizziness: 15,725 reports

Browse all side effects of Omeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Hallucinations treatments and more:

Hallucinations (84,577 reports)

COVID vaccines that are related to Hallucinations:

Common drugs associated with Hallucinations:

All the drugs that are associated with Hallucinations:

Hallucinations (3,199 drugs)

Common conditions associated with Hallucinations:

Parkinson's disease: 11,165 reports
Depression: 3,775 reports
Pain: 3,359 reports
Stress and anxiety: 2,192 reports

All the conditions that are associated with Hallucinations:

Hallucinations (2,618 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on omeprazole (the active ingredients of Omeprazole) and Omeprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.